Full View

In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

NS Hwang, S Varghese, HJ Lee… - Proceedings of the …, 2008 - National Acad Sciences
Development of clinically relevant regenerative medicine therapies using human embryonic
stem cells (hESCs) requires production of a simple and readily expandable cell population …
被引用次数：356 相关文章
[HTML] nih.gov

[HTML][HTML] In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

NS Hwang, S Varghese, HJ Lee, Z Zhang… - Proceedings of the …, 2008 - ncbi.nlm.nih.gov
Abstract Development of clinically relevant regenerative medicine therapies using human
embryonic stem cells (hESCs) requires production of a simple and readily expandable cell …

In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

NS Hwang, S Varghese, HJ Lee… - Proceedings of the …, 2008 - pure.johnshopkins.edu
Abstract Development of clinically relevant regenerative medicine therapies using human
embryonic stem cells (hESCs) requires production of a simple and readily expandable cell …

In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

NS Hwang, S Varghese, HJ Lee… - Proceedings of the …, 2008 - pubmed.ncbi.nlm.nih.gov
Development of clinically relevant regenerative medicine therapies using human embryonic
stem cells (hESCs) requires production of a simple and readily expandable cell population …

In vivo Commitment and Functional Tissue Regeneration Using Human Embryonic Stem Cell-Derived Mesenchymal Cells

NS Hwang, S Varghese, HJ Lee, Z Zhang, Z Ye… - Proceedings of the …, 2008 - JSTOR
Development of clinically relevant regenerative medicine therapies using human embryonic
stem cells (hESCs) requires production of a simple and readily expandable cell population …

In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

NS Hwang, S Varghese, HJ Lee, Z Zhang… - Proceedings of the …, 2008 - cir.nii.ac.jp
抄録< jats: p> Development of clinically relevant regenerative medicine therapies using
human embryonic stem cells (hESCs) requires production of a simple and readily …

In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells.

NS Hwang, S Varghese, HJ Lee, Z Zhang… - Proceedings of the …, 2008 - europepmc.org
Abstract Development of clinically relevant regenerative medicine therapies using human
embryonic stem cells (hESCs) requires production of a simple and readily expandable cell …

In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

NS Hwang, S Varghese, HJ Lee… - Proceedings of the …, 2008 - ui.adsabs.harvard.edu
Abstract Development of clinically relevant regenerative medicine therapies using human
embryonic stem cells (hESCs) requires production of a simple and readily expandable cell …
[PDF] researchgate.net

[PDF][PDF] In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

NS Hwanga, S Varghesea, HJ Leea, Z Zhanga, Z Yeb… - PNAS, 2008 - researchgate.net
Results Isolation and Characterization of Mesenchymal Precursor Cells from hESCs. hES-
derived MSCs were generated by selecting cells that are migrating from embryoid bodies …

In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells.

NS Hwang, S Varghese, HJ Lee, Z Zhang… - Proceedings of the …, 2008 - europepmc.org
Abstract Development of clinically relevant regenerative medicine therapies using human
embryonic stem cells (hESCs) requires production of a simple and readily expandable cell …